Hepatitis B virus IVDs

Pays: Australie

Langue: anglais

Source: Department of Health (Therapeutic Goods Administration)

Disponible depuis:

Cepheid Holdings Pty Ltd

classe:

Class 3

Fabriqué par:

Cepheid AB Rontgenvagen 5, Solna, SE-171 54 Sweden

Domaine thérapeutique:

CT704 - Hepatitis B virus IVDs

indications thérapeutiques:

The Cepheid Xpert? HBV Viral Load (VL) assay is an in vitro nucleic acid amplification test designed for the quantitation of Hepatitis B Virus (HBV) DNA in human serum or plasma (EDTA) from chronically HBV-infected individuals using the automated GeneXpert? Systems. The assay is intended for use in conjunction with clinical presentation and other laboratory markers as an indicator of disease prognosis and for use as an aid in assessing viral response to antiviral treatment as measured by changes in plasma or serum HBV DNA levels.The test is not intended to be used as a donor screening test for HBV, or to be used as a diagnostic test to confirm the presence of HBV infection.

Statut de autorisation:

A

Date de l'autorisation:

2019-10-17